Agilent Pharma Virtual Symposium - Day 2

ZÁZNAM | Proběhlo Čt, 18.2.2021

Během tohoto virtuálního sympózia budete moci poslouchat, jak Agilent a externí odborníci diskutují o inovativních řešeních pro řešení aktuálních požadavků v oblasti farmaceutických analýz.

Přejít na webinář

Agilent Technologies: Agilent 1st Pharma Virtual Symposium

The pharma industry is undergoing constant evolution, requiring implementation of more efficient process while experiencing more stringent regulatory requirements.

The ability to be fast to market, while maintaining a strong understanding of your product, is critical.

At Agilent, we understand your analytical requirements.

Thursday, 18th February - Live Broadcast

1. 10:15 a.m. – 11:15 a.m. CET The fundamentals of dissolution

Presenter: Owain McKenzie (EMEA Dissolution Business Team Manager, Agilent Technologies)

2. 12:00 p.m. – 01:00 p.m. CET Minimize Regulatory Risk by moving to a Customized Instrument Qualification Solution

Presenter: Garry Wright (European Laboratory Compliance Specialist, Agilent Technologies)

3. 03:00 p.m. – 04:00 p.m. CET Dissolution best practices and qualification

Presenter: Owain McKenzie (EMEA Dissolution Business Team Manager, Agilent Technologies)

Agilent Technologies

Agilent Pharma Virtual Symposium - Day 2

Thursday, 18th February - Live Broadcast

1. 10:15 a.m. – 11:15 a.m. CET The fundamentals of dissolution

2. 12:00 p.m. – 01:00 p.m. CET Minimize Regulatory Risk by moving to a Customized Instrument Qualification Solution

3. 03:00 p.m. – 04:00 p.m. CET Dissolution best practices and qualification

Mohlo by Vás zajímat

Deeper proteome coverage and faster throughput for single-cell samples on the Orbitrap Astral mass spectrometer

Purity quantification of tris(hydroxymethyl)aminomethane (TRIS) with IC

Quantitation of N-Nitroso-Propranolol in Drug Substance using LC-MS/MS

Analysis of PFAS by EPA Methods 533, 537.1, and 8327

DMT-on Purification of Phosphorothioate Oligonucleotide Using SHIMSEN Styra HLB SPE Cartridge